Depomed Inc (NASDAQ:DEPO) shares are trading lower by $0.48 at $14.42 in Tuesday's session.
The stock is under selling pressure as Sen. Claire McCaskill (D-Missouri) plans to investigate how drugmakers promote prescription pain pills that have may have led to thousands of overdoses and deaths over the years.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Depomed's stock, which peaked this year on January 4 at $21.38, has been mirrored in a slow and steady decline. It's now trading lower for the eighth time in its last nine trading sessions, with the one outlier being a small gain on March 24 of a nickel. Over that stretch, it has fallen from its March 16 close ($16.16) to a low of $14.13 that was reached earlier in today's session.
That marks the lowest level for Depomed since it bottomed in April 2016 at $13.57.